Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approaches

6 Sept 2024

Abstract excerpt

Tuberculosis(TB) of the Central nervous system (CNS) is a rare and highly destructive disease. The emergence of drug resistance has increased treatment difficulty, leaving the Bacillus Calmette-Guérin (BCG) vaccine as the only licensed preventative immunization available. This study focused on identifying the epitopes of PknD (Rv0931c) and Rv0986 from Mycobacterium tuberculosis(Mtb) strain H37Rv using an in...

Topics

Join the communities discussing this publication.

Monoclonal and Polyclonal Antibodies Research
Tuberculosis Research and Epidemiology
vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39240891
DOI: 10.1371/journal.pone.0307877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approachesPMID 39240891Read ↗

Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approachSemantic proximity Read ↗

Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modificationsSemantic proximity Read ↗

Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosisSemantic proximity Read ↗

A vaccine for global eradication of TB - A novel conceptual framework and design of a potent peptide-based vaccine with universal coverage through advanced computational vaccinologySemantic proximity Read ↗

In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinologySemantic proximity Read ↗

Advances in protein subunit vaccines against tuberculosisSemantic proximity Read ↗

An Immunoinformatic strategy to develop new Mycobacterium tuberculosis multi-epitope vaccineSemantic proximity Read ↗

Enhancing tuberculosis vaccine development: a deconvolution neural network approach for multi-epitope predictionSemantic proximity Read ↗

Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse VaccinologySemantic proximity Read ↗

Multi-epitope vaccine against drug-resistant strains of Mycobacterium tuberculosis: a proteome-wide subtraction and immunoinformatics approachSemantic proximity Read ↗

Design of a Multi-Epitope Vaccine against Tuberculosis from Mycobacterium tuberculosis PE_PGRS49 and PE_PGRS56 Proteins by Reverse VaccinologySemantic proximity Read ↗

In silico analysis of NHP2 membrane protein, a novel vaccine candidate present in the RD7 region of Mycobacterium tuberculosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.